文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis.

作者信息

Hirano Ikuo, Dellon Evan S, Falk Gary W, Gonsalves Nirmala P, Furuta Glenn T, Bredenoord Albert J

机构信息

Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.

出版信息

Gastroenterology. 2024 Jan;166(1):1-10. doi: 10.1053/j.gastro.2023.09.004. Epub 2023 Sep 9.

DOI:10.1053/j.gastro.2023.09.004

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10872872/

Abstract

摘要

相似文献

[1]

Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis.

Gastroenterology. 2024-1

[2]

Eosinophilic esophagitis: from discovery to effective treatment.

Allergy Asthma Proc. 2022-5-1

[3]

An update on Eosinophilic Esophagitis.

Acta Gastroenterol Belg. 2023

[4]

Eosinophilic Esophagitis: Lessons Learned from Its Evolution.

Dig Dis Sci. 2024-2

[5]

Concepts and Controversies in Eosinophilic Esophagitis: What's Coming Down the Pipe?

Gastroenterology. 2024-3

[6]

Eosinophilic Esophagitis: What's in a Name?

Dig Dis Sci. 2024-2

[7]

[Dysphagia with food impaction: suspected eosinophilic esophagitis].

MMW Fortschr Med. 2024-3

[8]

Apparent Increase in Eosinophilic Esophagitis Prevalence May Reflect Delayed Guideline Adoption.

Clin Gastroenterol Hepatol. 2024-4

[9]

Eosinophilic Gastrointestinal Disorders.

Pediatr Clin North Am. 2017-6

[10]

A Rare Case of Esophageal Granular Cell Tumor in Eosinophilic Esophagitis.

Clin Gastroenterol Hepatol. 2024-3

引用本文的文献

[1]

Eosinophilic Esophagitis without Eosinophils: Do You Want to Mock Me?

Inflamm Intest Dis. 2025-4-29

[2]

Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results.

Gastro Hep Adv. 2025-2-24

[3]

Mepolizumab Improves Histologic Severity as Measured by the EoEHSS in Adolescents and Adults With Eosinophilic Oesophagitis in a Multicenter, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.

Aliment Pharmacol Ther. 2025-5-29

[4]

Italian EoExpert panel recommendation for disease control, switching criteria, and follow-up in eosinophilic esophagitis from pediatric to adult age.

Therap Adv Gastroenterol. 2025-5-8

[5]

Endoscopic response to topical steroids is associated with a need for fewer future esophageal dilations.

Dis Esophagus. 2025-5-3

[6]

Histologic Response or Endoscopic Normalization After Initial Treatment for Eosinophilic Esophagitis in Children Leads to Less Fibrostenosis over Long-Term Follow-Up.

Dig Dis Sci. 2025-4

[7]

Roads to remission: evolving treatment concepts in type 2 inflammatory diseases.

EClinicalMedicine. 2025-1-8

[8]

Assessment of Disease Activity in Eosinophilic Esophagitis: Is It Clinically Relevant or Simply an Amusement for Experts?

Inflamm Intest Dis. 2024-12-10

[9]

Meta-Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled Trials.

Aliment Pharmacol Ther. 2025-1

[10]

Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs.

Inflamm Intest Dis. 2024-7-26

本文引用的文献

[1]

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.

N Engl J Med. 2022-12-22

[2]

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.

Gastroenterology. 2022-7

[3]

Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis.

Gastrointest Endosc. 2022-6

[4]

Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus.

Gastroenterology. 2021-9

[5]

Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial.

Clin Gastroenterol Hepatol. 2022-3

[6]

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

Gastroenterology. 2021-4

[7]

Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters.

Gastroenterology. 2020-5

[8]

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.

Gastroenterology. 2020-5

[9]

Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

J Allergy Clin Immunol. 2019-11-20

[10]

Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis.

J Gastroenterol. 2020-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索